172 related articles for article (PubMed ID: 25868746)
21. De novo design, synthesis and biological evaluation of 1,4-dihydroquinolin-4-ones and 1,2,3,4-tetrahydroquinazolin-4-ones as potent kinesin spindle protein (KSP) inhibitors.
Jiang C; Yang L; Wu WT; Guo QL; You QD
Bioorg Med Chem; 2011 Sep; 19(18):5612-27. PubMed ID: 21856161
[TBL] [Abstract][Full Text] [Related]
22. Fluorinated quinazolinones as potential radiotracers for imaging kinesin spindle protein expression.
Holland JP; Jones MW; Cohrs S; Schibli R; Fischer E
Bioorg Med Chem; 2013 Jan; 21(2):496-507. PubMed ID: 23245569
[TBL] [Abstract][Full Text] [Related]
23. Kinesin spindle protein (KSP) inhibitors. Part 7: Design and synthesis of 3,3-disubstituted dihydropyrazolobenzoxazines as potent inhibitors of the mitotic kinesin KSP.
Garbaccio RM; Tasber ES; Neilson LA; Coleman PJ; Fraley ME; Olson C; Bergman J; Torrent M; Buser CA; Rickert K; Walsh ES; Hamilton K; Lobell RB; Tao W; South VJ; Diehl RE; Davide JP; Yan Y; Kuo LC; Li C; Prueksaritanont T; Fernandez-Metzler C; Mahan EA; Slaughter DE; Salata JJ; Kohl NE; Huber HE; Hartman GD
Bioorg Med Chem Lett; 2007 Oct; 17(20):5671-6. PubMed ID: 17804233
[TBL] [Abstract][Full Text] [Related]
24. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
[TBL] [Abstract][Full Text] [Related]
25. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage.
Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB
Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598
[TBL] [Abstract][Full Text] [Related]
26. Bioisosteric approach in designing new monastrol derivatives: an investigation on their ADMET prediction using in silico derived parameters.
Hassan SF; Rashid U; Ansari FL; Ul-Haq Z
J Mol Graph Model; 2013 Sep; 45():202-10. PubMed ID: 24080467
[TBL] [Abstract][Full Text] [Related]
27. Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP.
Fraley ME; Garbaccio RM; Arrington KL; Hoffman WF; Tasber ES; Coleman PJ; Buser CA; Walsh ES; Hamilton K; Fernandes C; Schaber MD; Lobell RB; Tao W; South VJ; Yan Y; Kuo LC; Prueksaritanont T; Shu C; Torrent M; Heimbrook DC; Kohl NE; Huber HE; Hartman GD
Bioorg Med Chem Lett; 2006 Apr; 16(7):1775-9. PubMed ID: 16439123
[TBL] [Abstract][Full Text] [Related]
28. Conformation-dependent ligand regulation of ATP hydrolysis by human KSP: activation of basal hydrolysis and inhibition of microtubule-stimulated hydrolysis by a single, small molecule modulator.
Luo L; Carson JD; Molnar KS; Tuske SJ; Coales SJ; Hamuro Y; Sung CM; Sudakin V; Auger KR; Dhanak D; Jackson JR; Huang PS; Tummino PJ; Copeland RA
J Am Chem Soc; 2008 Jun; 130(24):7584-91. PubMed ID: 18491908
[TBL] [Abstract][Full Text] [Related]
29. Kinesin spindle protein (KSP) inhibitors in combination with chemotherapeutic agents for cancer therapy.
Song H; Zhou S; Wang R; Li S
ChemMedChem; 2013 Nov; 8(11):1736-49. PubMed ID: 23964020
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma.
De Monte C; Carradori S; Secci D; D'Ascenzio M; Guglielmi P; Mollica A; Morrone S; Scarpa S; Aglianò AM; Giantulli S; Silvestri I
Eur J Med Chem; 2015 Nov; 105():245-62. PubMed ID: 26498571
[TBL] [Abstract][Full Text] [Related]
31. The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphoma.
Bongero D; Paoluzzi L; Marchi E; Zullo KM; Neisa R; Mao Y; Escandon R; Wood K; O'Connor OA
Leuk Lymphoma; 2015; 56(10):2945-52. PubMed ID: 25860245
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells.
Carter BZ; Mak DH; Woessner R; Gross S; Schober WD; Estrov Z; Kantarjian H; Andreeff M
Leukemia; 2009 Oct; 23(10):1755-62. PubMed ID: 19458629
[TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis of annexin A2 phosphorylation induced by microtubule interfering agents and kinesin spindle protein inhibitors.
Fernandez-Garcia B; Casado P; Prado MA; Ugarte-Gil LJ; Artime N; Cabal-Hierro L; Calvo E; López JA; Ramos S; Lazo PS
J Proteome Res; 2010 Sep; 9(9):4649-60. PubMed ID: 20597553
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and bioevaluation of dihydropyrazolo[3,4-b]pyridine and benzo[4,5]imidazo[1,2-a]pyrimidine compounds as dual KSP and Aurora-A kinase inhibitors for anti-cancer agents.
Fu RG; You QD; Yang L; Wu WT; Jiang C; Xu XL
Bioorg Med Chem; 2010 Nov; 18(22):8035-43. PubMed ID: 20934346
[TBL] [Abstract][Full Text] [Related]
35. Kinesin spindle protein inhibitors in cancer: a patent review (2008 - present).
Jiang C; You Q
Expert Opin Ther Pat; 2013 Dec; 23(12):1547-60. PubMed ID: 23978071
[TBL] [Abstract][Full Text] [Related]
36. ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models.
Woessner R; Tunquist B; Lemieux C; Chlipala E; Jackinsky S; Dewolf W; Voegtli W; Cox A; Rana S; Lee P; Walker D
Anticancer Res; 2009 Nov; 29(11):4373-80. PubMed ID: 20032381
[TBL] [Abstract][Full Text] [Related]
37. [Synthesis and antitumor activity of novel tetrahydro-beta-carboline derivatives as KSP inhibitors].
Ruan XQ; Chen M; Wu WT; You QD
Yao Xue Xue Bao; 2013 Jul; 48(7):1119-23. PubMed ID: 24133978
[TBL] [Abstract][Full Text] [Related]
38. Recent progress in the identification and clinical evaluation of inhibitors of the mitotic kinesin KSP.
Knight SD; Parrish CA
Curr Top Med Chem; 2008; 8(10):888-904. PubMed ID: 18673173
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of biphenyl compounds as kinesin spindle protein inhibitors.
Holland JP; Kang A; Cohrs S; Selivanova SV; Milicevic Sephton S; Betzel T; Frey D; Wieser M; Jaussi R; Kammerer RA; Schibli R; Fischer E
Chem Biodivers; 2013 Apr; 10(4):538-55. PubMed ID: 23576341
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and evaluation of tetrahydroisoquinolines as new kinesin spindle protein inhibitors.
Jiang C; You Q; Liu F; Wu W; Guo Q; Chern J; Yang L; Chen M
Chem Pharm Bull (Tokyo); 2009 Jun; 57(6):567-71. PubMed ID: 19483335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]